Related Experiment Video
Updated: Jun 27, 2026

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
Price controls and global pharmaceutical progress
1John F. Kennedy School of Government, Harvard University, Cambridge, Massachusetts, USA. mike_scherer@harvard.edu
Abstract:
This Perspective reviews critically the work on price control impacts by Darius Lakdawalla and colleagues. It argues that the innovation elasticity of 3.0 emphasized by the authors is too high, exaggerating the long-run costs of price controls. It argues, too, that the drugs chosen for the authors' analysis are neither the most therapeutically innovative candidates nor those whose development is most likely to be discouraged by price controls.
Related Concept Videos
Drug Control Governance: Regulatory Bodies and Their Impact
Drug Regulation
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Drug Products: Biologics, Biosimilars and Interchangeables
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...

